Ciprofloxacin Hydrochloride Anhydrous → Ciprofloxacin

HRID 1522821

반응식

HRID 1522821 반응식
[CH:1]1[C:2]2[C:17](=[O:18])[C:16]([C:19]([OH:21])=[O:20])=[CH:15][N:14]([CH:22]3[CH2:24][CH2:23]3)[C:3]=2[CH:4]=[C:5]([N:8]2[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]2)[C:6]=1[F:7].Cl>C([O-])(=O)C.[Na+]>[CH:1]1[C:2]2[C:17](=[O:18])[C:16]([C:19]([OH:21])=[O:20])=[CH:15][N:14]([CH:22]3[CH2:23][CH2:24]3)[C:3]=2[CH:4]=[C:5]([N:8]2[CH2:9][CH2:10][NH:11][CH2:12][CH2:13]2)[C:6]=1[F:7]

참가 물질

3

반응물 1

HCID 62999Ciprofloxacin Hydrochloride Anhydrous

생성물 1

HCID 2764Ciprofloxacin

시약·촉매·용매 1

HCID 517045Sodium Acetate용매

실험 절차

Under aseptic manufacturing conditions, ciprofloxacin-HCl as powder was dissolved in 10 mM sodium acetate solution, pH 3.3 and sterile filtered resulting in a 24 mg/mL solution.

후처리

  1. filtrationpH 3.3 and sterile filtered
  2. customresulting in a 24 mg/mL solution

출처 및 근거

ORD 기록
ord-b31b746ff59648d9a9fd47a83d5ceaaa
출처 데이터셋
uspto-grants-2015_07
특허 번호
US09078897B1

연결된 노트

불러오는 중…